Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Home-BP Trial
NCT05159999Completed
- Sponsor
- University of Washington
- Start
- Feb 2022
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Randomised, open-label trial in end stage renal disease (ESRD) and hypertension (HTN) (3 arms), sponsored by University of Washington. Primary endpoint: Intradialytic hypotension at 10 months. Started Feb 2022; status: completed.
02
Conditions
end stage renal disease (ESRD)hypertension (HTN)
Beyond the preview
Go deeper on NCT05159999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05159999.